UNIKUM Therapeutics ApS: Financial statements 2024
CVR: 41192925
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
UNIKUM Therapeutics ApS (CVR 41192925) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -7,368,177 and a net result of DKK -13,797,011 compared with DKK -14,870,759 the year before. Equity in the 2024 report amounted to DKK -4,820,957. The company had 9 employees in the financial year.
- Gross Profit
- DKK -7,368,177
- Profit/Loss
- DKK -13,797,011
- Equity
- DKK -4,820,957
- Total Assets
- DKK 3,758,761
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -7.4M | -13.8M | -4.8M | 9 |
| 2023 | - | -7.5M | -14.9M | -16.3M | 9 |
| 2022 | - | -3.3M | -7.6M | -15.3M | 7 |
| 2021 | - | -2.7M | -5.6M | -7.6M | 5 |
| 2020 | - | -1.1M | -2.1M | -2.1M | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of October 1, 2024, Martin Roelsgaard Jakobsen is registered as director of UNIKUM Therapeutics ApS.
As of September 30, 2024, Tommi Petteri Kainu has stepped down as director of UNIKUM Therapeutics ApS.
As of August 12, 2024, Stefan Wildt has joined the board of directors of UNIKUM Therapeutics ApS.
As of August 12, 2024, Johannes Heinrich Frühauf has left the board of directors of UNIKUM Therapeutics ApS.
As of June 14, 2024, MR Jakobsen Holding ApS is registered as an owner of UNIKUM Therapeutics ApS with an ownership share of 15%.
UNIKUM Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -7,465,410, and the net result was DKK -14,870,759.
As of March 20, 2024, BII Holdings A/S is registered as an owner of UNIKUM Therapeutics ApS with an ownership share of 5%.
As of February 5, 2024, is registered as an owner of UNIKUM Therapeutics ApS with an ownership share of 33%.
About UNIKUM Therapeutics ApS
UNIKUM Therapeutics ApS is a Danish company of the type Anpartsselskab based in Risskov, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Roelsgaard Jakobsen. The board consists of Ulrik Bjerl Nielsen (chair), Martin Roelsgaard Jakobsen and Stefan Wildt. The company's owners include MEDIC ADVICE ApS, MR Jakobsen Holding ApS and BII Holdings A/S. The company has 2 employees (2025). In 2025, the company reported a gross profit of DKK -247,887 and a net result of DKK -859,076 compared with DKK -13,797,011 the year before. Equity in the 2025 report amounted to DKK -5,680,033.
